Quarterly report · Q2
4320.TEDINET S100TDO6
Period2023-10-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.1bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥13.6bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.3bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥741m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥840m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥744m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥838m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥744m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥861m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥372m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥688m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥495m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥405m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥536m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥12.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥11.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥11.2bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.1bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.3bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.4bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.1bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥451m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥796m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥289m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥353m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥862m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥254m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.0bn | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥755m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥194m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥24.77 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.68 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.91 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.99 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.5 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 49.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥25m |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥7.9bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥7.9bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥798m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥202m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥202m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥32m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥8.1bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥8.1bn |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥766m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥26m |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥873m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥8m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥7.3bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥7.3bn |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥865m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 482
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ncl | Prior1YearInstant | 173209000 | JPY |
| Other ncl | CurrentQuarterInstant | 165839000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1040277000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 2150722000 | JPY |
| Liabilities | Prior1YearInstant | 4660899000 | JPY |
| Liabilities | CurrentQuarterInstant | 6065812000 | JPY |
| Capital stock | Prior1YearInstant | 1218077000 | JPY |
| Capital stock | CurrentQuarterInstant | 1269825000 | JPY |
| Capital surplus | Prior1YearInstant | 1243929000 | JPY |
| Capital surplus | CurrentQuarterInstant | 1295678000 | JPY |
| Retained earnings | Prior1YearInstant | 3798845000 | JPY |
| Retained earnings | CurrentQuarterInstant | 3961278000 | JPY |
| Treasury stock | Prior1YearInstant | -200373000 | JPY |
| Treasury stock | CurrentQuarterInstant | -200404000 | JPY |
| Shareholders equity | Prior1YearInstant | 6060479000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 6326377000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 19114000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 27322000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 19114000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 27322000 | JPY |
| Subscription rights to shares | Prior1YearInstant | - | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 3585000 | JPY |
| Non controlling interests | Prior1YearInstant | 503507000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 466368000 | JPY |
| Net assets | Prior1YearInstant | 6583101000 | JPY |
| Net assets | CurrentQuarterInstant | 6823654000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 11244000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 12889466000 | JPY |
| Net sales | Prior1YTDDuration | 7341341000 | JPY |
| Net sales | CurrentYTDDuration | 8070171000 | JPY |
| Cost of sales | Prior1YTDDuration | 5378975000 | JPY |
| Cost of sales | CurrentYTDDuration | 6190754000 | JPY |
| Gross profit | Prior1YTDDuration | 1962366000 | JPY |
| Gross profit | CurrentYTDDuration | 1879417000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 1122790000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 1137934000 | JPY |
| Operating income | Prior1YTDDuration | 839575000 | JPY |
| Operating income | CurrentYTDDuration | 741483000 | JPY |
| Interest income noi | Prior1YTDDuration | 229000 | JPY |
| Interest income noi | CurrentYTDDuration | 19000 | JPY |
| Dividends income noi | Prior1YTDDuration | 1180000 | JPY |
| Dividends income noi | CurrentYTDDuration | 1045000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | - | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 640000 | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | 1739000 | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 4993000 | JPY |
| Other noi | Prior1YTDDuration | 3061000 | JPY |
| Other noi | CurrentYTDDuration | 3617000 | JPY |
| Non operating income | Prior1YTDDuration | 6211000 | JPY |
| Non operating income | CurrentYTDDuration | 10316000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |